You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《新股表現》聖諾醫藥(02257.HK)暗盤低開近9%報60元
根據輝立交易平台顯示,明天掛牌的聖諾醫藥-B(02257.HK)暗盤低開近9%報60元獲承接,掉頭曾高見68元,現報60.3元,較上市價65.9元,低8.5%,成交1,140股。 聖諾是一家核糖核酸(RNA)療法生物製藥公司。是次在港上市共發售754萬股,並已引入昆明佳時清及健新原力製藥為基石投資者,合共認購338.28萬股;其中10%公開發售獲約4.68倍超購,認購一手中籤率21.77%,股份以招股範圍(65.9-72.7元)下限定價,料集資淨額約3.96億元,主要用於發展及商業化公司核心產品STP705、用於STP707開發、撥付GalNAc計劃產品、其他臨床前階段候選產品,以及其他臨床前候選藥物研發等。上市獨家保薦人中金。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account